Literature DB >> 21917255

Characteristics of users of intrauterine devices and other reversible contraceptive methods in the United States.

Xin Xu1, Maurizio Macaluso, Jennifer Frost, John E Anderson, Kathryn Curtis, Scott D Grosse.   

Abstract

OBJECTIVE: To evaluate the determinants of intrauterine device (IUD) use and reasons for choosing IUDs over other reversible contraceptive methods.
DESIGN: Descriptive statistics and multinomial logistic regression were used to assess multiple factors associated with IUD use and the use of other reversible methods in the United States.
SETTING: Not applicable. PATIENT(S): Women at risk of pregnancy from the 2006 to 2008 National Survey of Family Growth and a 2004 Guttmacher Institute survey. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Sociodemographic and reproductive characteristics, family background, and health insurance coverage. RESULT(S): IUD use was positively associated with women's parity and the highest education level of respondent's mother; it was less common among women who had ≥4 sexual partners in the last 12 months and those who were widowed, divorced, or separated. IUD users reported pregnancy prevention, provider recommendation, and no interruption of sex as the most important reasons for choosing the method and reported a high level of satisfaction. CONCLUSION(S): IUD users differed substantially from users of other reversible contraceptives. IUD use was especially uncommon among nulliparae. Most current IUD users were satisfied with their choice. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917255     DOI: 10.1016/j.fertnstert.2011.08.019

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.

Authors:  Colleen McNicholas; Erin Swor; Leping Wan; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2017-01-29       Impact factor: 8.661

2.  Who is using long-acting reversible contraceptive methods? Findings from nine low-fertility countries.

Authors:  Mieke C W Eeckhaut; Megan M Sweeney; Jessica D Gipson
Journal:  Perspect Sex Reprod Health       Date:  2014-07-14

3.  Use of Intrauterine Devices and Risk of Human Immunodeficiency Virus Acquisition Among Insured Women in the United States.

Authors:  Julia L Marcus; Jonathan M Snowden; Mara E Murray Horwitz; Sengwee Toh; Casie Horgan; Rong Chen Tilney; Rajani Rajbhandari; Soowoo Back; Daniel J Westreich
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079

Review 4.  Long-Acting Reversible Contraception, Condom Use, and Sexually Transmitted Infections: A Systematic Review and Meta-analysis.

Authors:  Riley J Steiner; Sanjana Pampati; Katherine M Kortsmit; Nicole Liddon; Andrea Swartzendruber; Karen Pazol
Journal:  Am J Prev Med       Date:  2021-09-16       Impact factor: 6.604

5.  Knowledge and attitudes about long-acting reversible contraception among Latina women who desire sterilization.

Authors:  Kari White; Kristine Hopkins; Joseph E Potter; Daniel Grossman
Journal:  Womens Health Issues       Date:  2013 Jul-Aug

6.  Racial/ethnic disparities in contraceptive use: variation by age and women's reproductive experiences.

Authors:  Christine Dehlendorf; Seo Young Park; Chetachi A Emeremni; Diane Comer; Kathryn Vincett; Sonya Borrero
Journal:  Am J Obstet Gynecol       Date:  2014-02-01       Impact factor: 8.661

7.  Health insurance coverage and use of family planning services among current and former foster youth: implications of the health care reform law.

Authors:  Amy Dworsky; Kym Ahrens; Mark Courtney
Journal:  J Health Polit Policy Law       Date:  2012-12-21       Impact factor: 2.265

8.  Women's Use of Long-Acting Reversible Contraception for Birth Timing and Birth Stopping.

Authors:  Mieke C W Eeckhaut; Michael S Rendall; Polina Zvavitch
Journal:  Demography       Date:  2021-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.